Lunch & Learn: Leveraging IP for Strategic & Financial Value

​Leveraging IP for Strategic & Financial Value

​Intellectual property is one of the most consistently underleveraged assets in life science, and one of the most consequential for investors. Too often, IP is treated as a legal formality rather than a lever for value creation, leaving capital on the table at precisely the moments it matters most: fundraising, licensing, due diligence, and exit.

​In this Lunch & Learn, Invest in Equity welcomes Pernille Winding Gojkovic, CEO and Partner at HØIBERG and a European Patent Attorney specialising in life science IP, to explore how founders and investors can put IP to work strategically and financially across the innovation lifecycle.

​Drawing on two decades of experience advising spin-outs, university technology transfer offices, and early-stage investors, Pernille will cover what a strong IP position signals to capital, how IP strategy should map to financing milestones, and the questions every investor should be asking at each stage.

​45-minute presentation followed by a 15-minute live Q&A.

​About HØIBERG Founded in Copenhagen in 1995 by Susanne Høiberg, a medical doctor turned IP strategist, HØIBERG is a leading European IP firm with around 70 employees across six offices in Denmark, Sweden, and Iceland. Women have led the firm from the start, and that representation extends across its senior ranks today. HØIBERG advises innovative companies, spin-outs, and research institutions on the full spectrum of IP rights, with particular depth in life science.

​About Invest In Equity Invest in Equity is a mission-driven organisation advancing gender equity in life science investment, connecting the community to the knowledge, allies and networks needed to create long-term impact.